Related references
Note: Only part of the references are listed.Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
Deepak L. Bhatt et al.
CLINICAL CARDIOLOGY (2019)
Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes
Fabrice Schneider et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Systematic Review of Methods Used for the Microvascular Assessment of Peripheral Arterial Disease
Qinzhong Chen et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Sonia S. Anand et al.
LANCET (2018)
Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)
Francesco Vieceli Dalla Sega et al.
FRONTIERS IN PHYSIOLOGY (2018)
Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial
Robert S. Rosenson et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization
Connie N. Hess et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Effect of Ticagrelor Versus Clopidogrel on Vascular Reactivity
Mistre Alemayehu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
William R. Hiatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pathophysiology of Intermittent Claudication in Peripheral Artery Disease
Naomi M. Hamburg et al.
CIRCULATION JOURNAL (2017)
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
Katherine Kearney et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)
Marc P. Bonaca et al.
CIRCULATION (2016)
Vascular Complications of Diabetes
Joshua A. Beckman et al.
CIRCULATION RESEARCH (2016)
Endothelial Shear Stress and Blood Viscosity in Peripheral Arterial Disease
Young I. Cho et al.
CURRENT ATHEROSCLEROSIS REPORTS (2014)
Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
Duncan Armstrong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
Ann Wittfeldt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Ticagrelor induces adenosine triphosphate release from human red blood cells
Jenny Ohman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Importance of Blood Rheology in the Pathophysiology of Atherothrombosis
Aimee Q. Cowan et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
High Blood Viscosity Is Closely Associated With Cigarette Smoking and Markedly Reduced by Smoking Cessation
Sayaka Shimada et al.
CIRCULATION JOURNAL (2011)
Treatment with Aspirin and Dipyridamole is More Effective than Aspirin in Reducing Low Shear Blood Viscosity
Robert S. Rosenson
MICROCIRCULATION (2008)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease
SG Wannamethee et al.
EUROPEAN HEART JOURNAL (2005)
Prevalence of and risk factors for peripheral arterial disease in the United States - Results from the National Health and Nutrition Examination Survey, 1999-2000
E Selvin et al.
CIRCULATION (2004)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part II
TF Lüscher et al.
CIRCULATION (2003)
Variations of whole blood viscosity using Rhelog™ -: a new scanning capillary viscometer
SH Wang et al.
CLINICA CHIMICA ACTA (2003)
Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication
DL Dawson et al.
ANGIOLOGY (2002)
Share Paper
